Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Non-Current Debt (2016 - 2021)

Creative Medical Technology Holdings (CELZ) has disclosed Non-Current Debt for 6 consecutive years, with $52582.0 as the latest value for Q2 2021.

  • Quarterly Non-Current Debt rose 18546.1% to $52582.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $52582.0 through Jun 2021, up 18546.1% year-over-year, with the annual reading at $18782.0 for FY2020, 22804.88% up from the prior year.
  • Non-Current Debt for Q2 2021 was $52582.0 at Creative Medical Technology Holdings, up from $5082.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $198082.0 in Q4 2018, with the low at $82.0 in Q4 2019.
  • Average Non-Current Debt over 5 years is $35057.7, with a median of $11282.0 recorded in 2020.
  • The sharpest move saw Non-Current Debt crashed 99.96% in 2019, then surged 22804.88% in 2020.
  • Over 5 years, Non-Current Debt stood at $25000.0 in 2017, then skyrocketed by 692.33% to $198082.0 in 2018, then plummeted by 99.96% to $82.0 in 2019, then soared by 22804.88% to $18782.0 in 2020, then skyrocketed by 179.96% to $52582.0 in 2021.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $52582.0, $5082.0, and $18782.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.